Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

OncoVista Innovative Therapies Inc

+ Add to Watchlist

OVIT:US

0.3400 USD 0.0451 15.29%

As of 20:10:01 ET on 03/03/2015.

Snapshot for OncoVista Innovative Therapies Inc (OVIT)

Open: 0.2999 Day's Range: 0.2899 - 0.3400 Volume: 10,584
Previous Close: 0.2949 52wk Range: 0.0066 - 1.7500 1-Yr Rtn: +209.97%

Stock Chart for OVIT

No chart data available.
  • OVIT:US 0.3400
  • 1D
  • 1M
  • 1Y
0.2949
Interactive OVIT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for OVIT

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 7.35
Shares Outstanding (M) 21.63
30 Day Average Volume 31,665
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for OVIT

No data available

Company Profile & Key Executives for OVIT

OncaVista Innovatice Therapies, Inc. develops and commercializes targeted cancer therapies for safer and more efficacious treatment of cancer. The Company offers their therapies both through the acquisition of rights to technologies and drugs from others and through the development of their own proprietary products.

Alexander L WeisChairman/President/CEO
More Company Profile & Key Executives for OVIT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil